Since 2008, Spiegelman has been the Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Dana–Farber Cancer Institute and Harvard Medical School, and director of the Center for Metabolism and Chronic Disease at the Dana-Farber.
[1] Following his postdoctoral training in 1982, Spiegelman joined the faculty at Harvard Medical School (HMS) and the Dana–Farber Cancer Institute.
A few years later, Spiegelman and his colleagues found that the adipose tissues express TNF and other cytokines in rodent and human obesity.
[7] Two years following the original discovery, Spiegelman and colleagues discovered a transcriptional coactivator called PGC-1 alpha and a sister gene he named PGC-1 beta in 2002.
[10] Since 2008, Spiegelman has been the Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Dana–Farber Cancer Institute and Harvard Medical School, and director of the Center for Metabolism and Chronic Disease at the Dana-Farber.
[14] As a result of his research, Spiegelman received the Frederick Banting Medal of the American Diabetes Association in 2012[15] and the Manpei Suzuki Prize in 2013.